Strategic sale of Hindustan Antibiotics, Bengal Chemicals cleared

Our Bureau New Delhi | Updated on July 17, 2019 Published on July 17, 2019

The Cabinet on Wednesday decided to close down State-owned Indian Drugs and Pharmaceutical Ltd (IDPL) and its subsidiary Rajasthan Drugs and Pharmaceuticals Ltd (RDPL) and put two others — Hindustan Antibiotics Ltd (HAL) and Bengal Chemicals and Pharmaceuticals Ltd (BCPL) — on strategic sale.

“While the IDPL and RDPL will be closed and their land will be sold, strategic sale will be carried in HAL and BCPL,” said Information and Broadcasting Minister Prakash Javadekar.

The sale and closure will be as per the revised guidelines of the Department of Public Enterprises and a Committee of Ministers will be constituted to take decisions relating to their closure/ strategic sale, including the sale of assets and clearance of outstanding liabilities.

A sum of ₹330 crore from the funds raised would be spent on paying salary arrears and offering VRS to employees of these companies, he said. According to an official statement, these public sector units have more than 1,000 employees. While the funds required to compensate HAL employees are around ₹280 crore, IDPL and RDPL would need ₹6.5 crore and ₹43.7 crore respectively, the statement said.

The decision assumes significance because the government has been trying to monetise the assets of these sick public sector pharma companies since December 2016, but could not do so. This was because workers in many of these units legally challenged the decision to sale the surplus land belonging to these firms to other government agencies. Even though the government issued tenders more than once, it could not get buyers for the same.

Instead of strengthening these state-owned pharm companies, which have been supplying medicines at cheaper rates to to government hospitals, the government wants to close them down to please private pharma companies, both domestic and foreign, said a trade union leader based in Delhi.

Published on July 17, 2019

A letter from the Editor

Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!


Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.